Varun Sriram 
Dealstreet

JSA assists Vizag Hospital and Cancer Research Centre on sale of shares

The enterprise value of the deal is ₹4,140 million.

Bar & Bench

Vizag Hospital and Cancer Research Centre Private Limited has proposed a sale of shares in Vizag Hospital to HealthCare Global Enterprises Limited for an Enterprise Value of ₹4,140 million.

The transaction is proposed to be completed in multiple tranches wherein HCG will acquire 51% of the equity share capital in Vizag Hospital in the first tranche and intends to complete the second tranche of acquisition of 34% of the equity share capital in the next 18 months.

The acquisition of the balance 15% of the equity share capital in Vizag Hospital may be pursuant to a time bound call option or put option.

JSA represented Vizag Hospital and Cancer Research Centre Private Limited and its shareholders on this transaction.

The transaction team consists of Varun Sriram (Lead Partner), Varsha Srinivasan (Principal Associate) and Nandini Menon V (Associate).

Vizag Hospital, owns and operates a comprehensive cancer care hospital in the city of Vishakhapatnam, Andhra Pradesh, with a well-built hospital infrastructure, led by Dr. Murali Krishna Voonna, a renowned onco-surgeon. The hospital boasts 196 operational beds and features advanced medical infrastructure.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

CAM, JSA, Hogan Lovells act on TVS Infrastructure Trust ₹1,300 crore IPO

Himachal Pradesh High Court restrains sale of Old Mist rum after Old Monk alleges trademark violation

Saraf, SAM, AZB, Kirkland act on secondary acquisition of securities in Fractal multiple investors

NovoJuris Legal acts on Maieutic Semiconductor fundraise

Unchecked Misuse of Power under SEBI’s PIT Regulations

SCROLL FOR NEXT